Deutsche Bank’s Titan Pharmaceuticals TTNP Stock Holding History

Deutsche Bank’s Portfolio TTNP Stock Details TTNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-306	Closed	-$35K	–	4825
2019 Q4	$35K	Buy	+306	New	+$36.9K	﹤0.01%	4102
2019 Q2	–	Sell	-1	Closed	–	–	5513
2019 Q1	$0	Sell	1 -1	-50%	-$971	﹤0.01%	5439
2018 Q4	$1K	Buy	+2	New	+$2.24K	﹤0.01%	5115
2018 Q2	–	Hold	0	–	–	–	5617
2018 Q1	–	Hold	0	–	–	–	5601
2017 Q4	–	Hold	0	–	–	–	5145
2017 Q3	–	Sell	-15	Closed	-$92.9K	–	5089
2017 Q2	$103K	Buy	15 +9	+150%	+$83.7K	﹤0.01%	4194
2017 Q1	$72K	Buy	6 +1	+20%	+$14.1K	﹤0.01%	4066
2016 Q4	$75K	Buy	5 +4	+400%	+$67.3K	﹤0.01%	4206
2016 Q3	$18K	Hold	1	–	–	﹤0.01%	4559
2016 Q2	$15K	Buy	+1	New	+$21.3K	﹤0.01%	4831
2016 Q1	–	Sell	-6	Closed	-$91K	–	5339
2015 Q4	$91K	Buy	+6	New	+$97.7K	﹤0.01%	4109

Other funds holding TTNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ECM

ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

CWM

Cornerstone Wealth Management St. Peters, Missouri $2B AUM 19.19% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Deutsche Bank's TTNP Position: Q1 2020 in Review

Deutsche Bank sold out of Titan Pharmaceuticals (TTNP) in Q1 2020, closing a stake of 306 shares — an estimated $35K sold.

Deutsche Bank first reported a position in TTNP in Q4 2015 and held it in 9 quarters. The position peaked at $103K in Q2 2017. 19 funds tracked by Wall St. Rank hold TTNP as of Q1 2020.

Deutsche Bank reported no remaining Titan Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Deutsche Bank sold 306 Titan Pharmaceuticals shares in Q1 2020, an estimated $35K.
Deutsche Bank first reported a position in Titan Pharmaceuticals in Q4 2015 and held it in 9 quarters.
Deutsche Bank's Titan Pharmaceuticals position peaked at $103K in Q2 2017.
19 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.